Induction of stem-like cells with malignant properties by chronic exposure of human lung epithelial cells to single-walled carbon nanotubes

Particle and Fibre Toxicology

Volumn 11, Issue 1, 2014, Pages

  Luanpitpong, Sudjit ^a   Wang, Liying ^b   Castranova, Vincent ^b   Rojanasakul, Yon ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Carbon nanotubes; Lung epithelial cells; Malignant transformation; Stem cells; Tumorigenesis

Indexed keywords

CD133 ANTIGEN; CD24 ANTIGEN; PROTEIN P53; SINGLE WALLED NANOTUBE; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX17; TRANSCRIPTION FACTOR SOX2; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CARCINOGENICITY; CELL INVASION; CELL ISOLATION; CELL MIGRATION; CELL REGENERATION; CELL RENEWAL; CELL SUBPOPULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; LUNG CARCINOGENESIS; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR PROMOTION;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CELL LINE; CELL MOVEMENT; EPITHELIAL CELLS; FLOW CYTOMETRY; HUMANS; LUNG; LUNG NEOPLASMS; MICE; NANOTUBES, CARBON; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; PLASMIDS; STEM CELLS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84901666512     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/1743-8977-11-22     Document Type: Article

References (69)

1. Shvedova AA, Kisin ER, Porter D, Schulte P, Kagan VE, Fadeel B, Castranova V. Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: two faces of Janus?. Pharmacol Ther 2009, 121:192-204. 10.1016/j.pharmthera.2008.10.009, 19103221.
2. Helland A, Wick P, Koehler A, Schmid K, Som C. Reviewing the environmental and human health knowledge base of carbon nanotubes. Environ Health Perspect 2007, 115:1125-1131. 10.1289/ehp.9652, 1940104, 17687437.
3. Snyder-Talkington BN, Schwegler-Berry D, Castranova V, Qian Y, Guo NL. Multi-walled carbon nanotubes induce human microvascular endothelial cellular effects in an alveolar-capillary co-culture with small airway epithelial cells. Part Fibre Toxicol 2013, 10:35. 10.1186/1743-8977-10-35, 3750368, 23903001.
4. Donaldson K, Aitken R, Tran L, Stone V, Duffin R, Forrest G, Alexandra A. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci 2006, 92:5-22. 10.1093/toxsci/kfj130, 16484287.
5. Jaurand MCF, Renier A, Daubriac J. Mesothelioma: do asbestos and carbon nanotubes pose the same health risk?. Part Fibre Toxicol 2009, 6:16. 10.1186/1743-8977-6-16, 2706793, 19523217.
6. Shvedova AA, Kapralov AA, Feng WH, Kisin ER, Murray AR, Mercer RR, St Croix CM, Lang MA, Watkins SC, Konduru NV, Allen BL, Conroy J, Kotchey GP, Mohamed BM, Meade AD, Volkov Y, Star A, Fadeel B, Kagan VE. Impaired clearance and enhanced pulmonary inflammatory/fibrotic response to carbon nanotubes in myeloperoxidase-deficient mice. PLoS One 2012, 7:e30923. 10.1371/journal.pone.0030923, 3316527, 22479306.
7. Mercer RR, Scabilloni J, Wang L, Kisin E, Murray AR, Schwegler-Berry D, Shvedova AA, Castranova V. Alteration of deposition pattern and pulmonary response as a result of improved dispersion of aspirated single-walled carbon nanotubes in a mouse model. Am J Physiol Lung Cell Mol Physiol 2008, 294:L87-L97.
8. Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AL, Tyurina YY, Gorelik O, Arepalli S, Schwegler-Berry D, Hubbs AF, Antonini J, Evans DE, Ku BK, Ramsey D, Maynard A, Kagan VE, Castranova V, Baron P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 2005, 289:L698-L708. 10.1152/ajplung.00084.2005, 15951334.
9. Mercer RR, Hubbs AF, Scabilloni JF, Wang L, Battelli LA, Schwegler-Berry D, Castranova V, Porter DW. Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part Fibre Toxicol 2010, 7:28. 10.1186/1743-8977-7-28, 2958975, 20920331.
10. Mercer RR, Hubbs AF, Scabilloni JF, Wang L, Battelli LA, Castranova V, Porter DW. Pulmonary fibrotic response from inhaled multiwalled carbon nanotube exposure in mice. The Toxicologist 2012, 126:A1806.
11. Donaldson K, Murphy FA, Duffin R, Poland CA. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role on long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 2010, 7:5. 10.1186/1743-8977-7-5, 2857820, 20307263.
12. Bernstein DM, Riego Sintes JM, Kjaer Ersboell B, Kunert J, Riego Sintes JM, Kjaer Ersboell B, Kunert J, Riego Sintes JM, Kjaer Ersboell B, Kunert J. Biopersistence of synthetic mineral fibers as a predictor of chronic intraperitoneal injection tumour response in rats. Inhal Toxicol 2001, 13:851-875. 10.1080/089583701752378142, 11696864.
13. Hesterberg TW, Chase G, Axten C, Miller WC, Musselman RP, Kamstrup O, Hadley J, Morscheldt C, Bernstein DM, Thevenaz P. Biopersistence of synthetic vitreous fibers and amosite asbestos in the rat lung following inhalation. Toxicol Appl Pharmacol 1998, 151:262-275. 10.1006/taap.1998.8472, 9707503.
14. Davoren M, Herzog E, Casey A, Cottineau B, Chambers G, Byrne HJ, Lyng FM. In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells. Toxicol in Vitro 2007, 21:438-448. 10.1016/j.tiv.2006.10.007, 17125965.
15. Lindberg HK, Falck GC, Suhonen S, Vippola M, Vanhala E, Catalan J, Savolainen K, Norppa H. Genotoxicity of nanomaterials: DNA damage and micronuclei induced by carbon nanotubes and graphite nanofibres in human bronchial epithelial cells in vitro. Toxicol Lett 2009, 186:166-173. 10.1016/j.toxlet.2008.11.019, 19114091.
16. Sargent LM, Shvedova AA, Hubbs AF, Salisbury JL, Benkovic SA, Kashon ML, Lowry DT, Murray AR, Kisin ER, Friend S, McKinstry KT, Battelli L, Reynolds SH. Induction of aneuploidy by single-walled carbon nanotubes. Environ Mol Mutagen 2009, 50:708-717. 10.1002/em.20529, 19774611.
17. Pacurari M, Yin XJ, Zhao J, Ding M, Leonard SS, Schwegler-Berry D, Ducatman BS, Sbarra D, Hoover MD, Castranova V, Vallyathan V. Raw single-wall carbon nanotubes induce oxidative stress and activate MAPKs, AP-1, NF-kappaB, and Akt in normal and malignant human mesothelial cells. Environ Health Perspect 2008, 116:1211-1217. 10.1289/ehp.10924, 2535624, 18795165.
18. Chou CC, Hsiao HY, Hong QS, Chen CH, Peng YW, Chen HW, Yang PC. Single-walled carbon nanotubes can induce pulmonary injury in mouse model. Nano Lett 2008, 8:437-445. 10.1021/nl0723634, 18225938.
19. Takagi A, Hirose A, Nishimura T, Fukumori N, Ogata A, Ohashi N, Kitajima S, Kanno J. Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. J Toxicol Sci 2008, 33:105-116. 10.2131/jts.33.105, 18303189.
20. Kanno J, Takagi A, Nishimura T, Hirose A. Mesothelioma induction by micrometer-sized multi-walled carbon nanotube intraperitoneally injected to p53 heterozygous mice. Toxicologist 2010, 114:A1397.
21. Poland CA, Duffin R, Kinloch L, Maynard A, Wallace WAH, Seaton A, Stone V, Brown S, MacNee W, Donaldson K. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 2008, 3:423-428. 10.1038/nnano.2008.111, 18654567.
22. Shvedova AA, Kisin E, Murray AR, Johnson VJ, Gorelik O, Arepalli S, Hubbs AF, Mercer RR, Keohavong P, Sussman N, Jin J, Yin J, Stone S, Chen BT, Deye G, Maynard A, Castranova V, Baron PA, Kagan VE. Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am J Physiol Lung Cell Mol Physiol 2008, 295:L552-L565. 10.1152/ajplung.90287.2008, 2575941, 18658273.
23. Shukla A, Vacek P, Mossman BT. Dose-response relationships in expression of biomarkers of cell proliferation in in vitro assays and inhalation experiments. Nonlinearity Biol Toxicol Med 2004, 2:117-128. 10.1080/15401420490464420, 2655707, 19330127.
24. Wang L, Luanpitpong S, Castranova V, Tse W, Lu Y, Pongrakhananon V, Rojanasakul Y. Carbon nanotubes induce malignant transformation and tumorigenesis of human lung epithelial cells. Nano Lett 2011, 11:2796-2803. 10.1021/nl2011214, 3135732, 21657258.
25. Wang L, Stueckle T, Mishra A, Derk R, Meighan T, Castranova V, Rojanasakul Y. Neoplastic-like transformation effect of single-walled and multi-walled carbon nanotubes compared to asbestos on human lung small airway epithelial cells. Nanotoxicology 2014, 8:485-507. 10.3109/17435390.2013.801089, 23634900.
26. Lohchareonkal W, Wang L, Stueckle T, Dinu CZ, Castranova V, Liu Y, Rojanasakul Y. Chronic exposure to carbon nanotubes induces invasion of human mesothelial cells through matrix metalloproteinase-2. ACS Nano 2013, 7:7711-7723. 10.1021/nn402241b, 23924264.
27. Ailles LE, Weissman IL. Cancer stem cells in solid tumors. Curr Opin in Biotech 2007, 18:460-466.
28. Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concepts. Annu Rev Med 2007, 58:267-284. 10.1146/annurev.med.58.062105.204854, 17002552.
29. Christgen M, Geffers R, Ballmaier M, Christgen H, Poczkaj J, Krech T, Kreipe H, Lehmann U. Down-regulation of the fetal stem cell factor sox17 by H33342: a mechanism responsible for differential gene expression in breast cancer side population cells. J Biol Chem 2010, 285:6412-6418. 10.1074/jbc.M109.082941, 2825436, 20040597.
30. Ho MM, Ng AV, Lam S, Hung JY. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 2007, 67:4827-4833. 10.1158/0008-5472.CAN-06-3557, 17510412.
31. Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One 2008, 3:e3077. 10.1371/journal.pone.0003077, 2518121, 18728788.
32. Wang L, Castranova V, Mishra A, Chen B, Mercer RR, Schwegler-Berry D, Rojanasakul Y. Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies. Part Fibre Toxicol 2010, 7:31. 10.1186/1743-8977-7-31, 2970581, 20958985.
33. Stone KC, Mercer RR, Gehr P, Stockstill B, Crapo JD. Allometric relationships of cell numbers and size in the mammalian lung. Am J Respir Cell Mol Biol 1992, 6:235-243. 10.1165/ajrcmb/6.2.235, 1540387.
34. Han JH, Lee EJ, Lee JH, So KP, Lee YH, Bae GN, Lee SB, Ji JH, Cho MH, Yu IJ. Monitoring multiwalled carbon nanotube exposure in carbon nanotube research facility. Inhal Toxicol 2008, 20:741-749. 10.1080/08958370801942238, 18569096.
35. Erdely A, Dahm M, Chen BT, Birch ME, Evans DE, Schubauer-Berigan M, Hulderman T, Bilgesu SA, Leonard HD, McKinney W, Frazer DG, Antonini JM, Porter DW, Castranova V, Schubauer-Berigan MK. Carbon nanotube dosimetry: from workplace exposure assessment to inhalation toxicology. Part Fibre Toxicol 2013, 10:53. 10.1186/1743-8977-10-53, 4015290, 24144386.
36. Levina V, Marrangoni A, Wang T, Parikh S, Su Y, Herberman R, Lokshin A, Gorelik E. Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop. Cancer Res 2010, 70:338-346. 10.1158/0008-5472.CAN-09-1102, 20028869.
37. Colburn NH, Bruegge WF, Bates JR, Gray RH, Rossen JD, Kelsey WH, Shimada T. Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells. Cancer Res 1978, 38:624-634.
38. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003, 17:1253-1270. 10.1101/gad.1061803, 196056, 12756227.
39. Romano AC, Espana EM, Yoo SH, Budak MT, Wolosin JM, Tseng SC. Different cell sizes in human limbal and central corneal basal epithelia measured by confocal microscopy and flow cytometry. Ophthalmol Vis Sci 2003, 44:5125-5129.
40. Mitsutake N, Iwao A, Nagai K, Namba H, Ohtsuru A, Saenko V, Yamashita S. Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology 2007, 148:1797-1803. 10.1210/en.2006-1553, 17234707.
41. Kruyt FA, Schuringa JJ. Apoptosis and cancer stem cells: Implications for apoptosis targeted therapy. Biochem Pharmacol 2010, 80:423-430. 10.1016/j.bcp.2010.04.010, 20394737.
42. Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003, 3:362-374. 10.1038/nrc1075, 12724734.
43. Ullmann R, Bongiovanni M, Halbwedl I, Petzmann S, Gogg-Kammerer M, Sapino A, Papotti M, Bussolati G, Popper HH. Bronchiolar columnar cell dysplasia-genetic analysis of a novel preneoplastic lesion of peripheral lung. Virchows Arch 2003, 442:429-436.
44. Jaggupilli A, Elkord E. Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity. Clin Dev Immunol 2012, 2012:708036. 3369436, 22693526.
45. Mizugaki H, Sakakibara-Konishi J, Kikuchi J, Moriya J, Hatanaka KC, Kikuchi E, Kinoshita I, Oizumi S, Dosaka-Akita H, Matsuno Y, Nishimura M. CD133 expression: a potential prognostic marker for non-small cell lung cancers. Int J Oncol 2013, doi:10.1007/s10147-013-0541-x.
46. Samel JM. Environmental causes of cancer: what do we know in 2003?. Chest 2004, 125:80S-83S. 10.1378/chest.125.5_suppl.80S, 15136426.
47. Samet JM, Avila-Tang E, Boffetta P, Hannan LM, Olivo-Marston S, Thun MJ, Rudin CM. Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin Cancer Res 2009, 15:5625-5645.
48. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401. 10.1038/nature03128, 15549107.
49. Jia G, Wang H, Yan L, Wang X, Pei R, Yan T, Zhao Y, Guo X. Cytotoxicity of carbon nanomaterials: single-wall nanotube, multi-wall nanotube, and fullerene. Environ Sci Technol 2005, 39:1378-1383. 10.1021/es048729l, 15787380.
50. Tian F, Cui D, Schwarz H, Estrada GG, Kobayashi H. Cytotoxicity of single-wall carbon nanotubes on human fibroblasts. Toxicol In Vitro 2006, 20:1201-1212.
51. Hu X, Cook S, Wang P, Hwang HM, Liu X, Williams QL. In vitro evaluation of cytotoxicity of engineered carbon nanotubes in selected human cell lines. Sci Total Environ 2010, 408:1812-1817. 10.1016/j.scitotenv.2010.01.035, 20167353.
52. Mercer RR, Hubbs AF, Scabilloni JF, Wang L, Battelli LA, Friend S, Castranova V, Porter DW. Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes. Part Fibre Toxicol 2011, 8:21. 10.1186/1743-8977-8-21, 3152886, 21781304.
53. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000, 100:57-70. 10.1016/S0092-8674(00)81683-9, 10647931.
54. Gatenby RA, Gillies RJ. A microenvironmenal model of carcinogenesis. Nat Rev Cancer 2008, 8:56-61. 10.1038/nrc2255, 18059462.
55. Mieault MM, Hauke R, Mehta PP, Batra SK. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med 2007, 11:981-1011. 10.1111/j.1582-4934.2007.00088.x, 17979879.
56. Stenner-Liewen F, Reed JC. Apoptosis and cancer: basic mechanisms and therapeutic opportunities in the postgenomic era. Cancer Res 2003, 63:263-268.
57. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006, 127:679-695. 10.1016/j.cell.2006.11.001, 17110329.
58. Noh KH, Kim BW, Song KH, Cho H, Lee YH, Kim JH, Chung JY, Kim JH, Hewitt SM, Seong SY, Mao CP, Wu TC, Kim TW. Nanog signaling in cancer promotes stem-like phenotype and immune evasion. J Clin Invest 2012, 122:4077-4093. 10.1172/JCI64057, 3484451, 23093782.
59. Jeter CR, Liu B, Liu X, Chen X, Liu C, Calhoun-Davis T, Repass J, Zaehres H, Shen JJ, Tang DG. NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 2011, 30:3833-3845. 10.1038/onc.2011.114, 3140601, 21499299.
60. Chen S, Xu Y, Chen Y, Li X, Mou W, Wang L, Liu Y, Reisfeld RA, Xiang R, Lv D, Li N. SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells. PLoS One 2012, 7:e36326. 10.1371/journal.pone.0036326, 3352903, 22615765.
61. Xiang R, Liao D, Cheng T, Zhou H, Shi Q, Chuang TS, Markowitz D, Reisfeld RA, Luo Y. Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. Br J Cancer 2011, 104:1410-1417. 10.1038/bjc.2011.94, 3101944, 21468047.
62. Akunuru S, James Zhai O, Zheng Y. Non-small cell lung cancer stem/progenitor cells are enriched in multiple distinct phenotypic subpopulations and exhibit plasticity. Cell Death Dis 2012, 3:e352. 10.1038/cddis.2012.93, 3406592, 22825470.
63. Wei W, Hu H, Tan H, Chow LW, Yip AY, Loo WT. Relationship of CD44 + CD24-/low breast cancer stem cells and axillary lymph node metastasis. J Transl Med 2012, 10:S6. 10.1186/1479-5876-10-S1-S6, 3445858, 23046710.
64. Chen YC, Hsu HS, Chen YW, Tsai TH, How CK, Wang CY, Hung SC, Chang YL, Tsai ML, Lee YY, Ku HH, Chiou SH. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One 2008, 3:e2637. 10.1371/journal.pone.0002637, 2440807, 18612434.
65. Bertolinia G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, Calabro E, Pastorino U, Sozzi G. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A 2009, 106:16281-16286. 10.1073/pnas.0905653106, 2741477, 19805294.
66. Iida H, Suzuki M, Goitsuka R, Ueno H. Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2. Int J Oncology 2012, 40:71-79.
67. Ozaki T, Nakagawara A. Role of p53 in cell death and human cancers. Cancers 2011, 3:994-1013. 10.3390/cancers3010994, 3756401, 24212651.
68. Piao CQ, Liu L, Zhao YL, Balajee AS, Suzuki M, Hei TK. Immortalizaiton of human small airway epithelial cells by ectopic expression of telomerase. Carcinogenesis 2005, 26:725-731. 10.1093/carcin/bgi016, 15677631.
69. Clark GJ, Cox AD, Graham SM, Der CJ. Biological assays for Ras transformation. Methods Enzymol 1995, 255:395-412.